GF Fund Management CO. LTD. Makes New Investment in The Cooper Companies, Inc. (NASDAQ:COO)

GF Fund Management CO. LTD. bought a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 4,871 shares of the medical device company's stock, valued at approximately $448,000.

Several other hedge funds have also recently made changes to their positions in COO. Barclays PLC boosted its position in shares of Cooper Companies by 0.7% during the third quarter. Barclays PLC now owns 462,947 shares of the medical device company's stock valued at $51,082,000 after purchasing an additional 3,070 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Cooper Companies by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock valued at $543,979,000 after purchasing an additional 573,908 shares in the last quarter. Atomi Financial Group Inc. boosted its position in shares of Cooper Companies by 26.2% during the fourth quarter. Atomi Financial Group Inc. now owns 3,091 shares of the medical device company's stock valued at $284,000 after purchasing an additional 641 shares in the last quarter. SG Americas Securities LLC boosted its position in shares of Cooper Companies by 34.9% during the fourth quarter. SG Americas Securities LLC now owns 4,380 shares of the medical device company's stock valued at $403,000 after purchasing an additional 1,134 shares in the last quarter. Finally, Exchange Traded Concepts LLC boosted its position in shares of Cooper Companies by 17.9% during the fourth quarter. Exchange Traded Concepts LLC now owns 1,292 shares of the medical device company's stock valued at $119,000 after purchasing an additional 196 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

Cooper Companies stock traded down $11.45 during mid-day trading on Friday, reaching $68.51. 4,546,464 shares of the stock traded hands, compared to its average volume of 1,525,147. The stock has a market capitalization of $13.70 billion, a PE ratio of 35.04, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a 12-month low of $66.03 and a 12-month high of $112.38. The business's 50-day moving average is $80.12 and its 200-day moving average is $88.69.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. The company had revenue of $1 billion during the quarter, compared to analysts' expectations of $995.12 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.85 earnings per share. As a group, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Stifel Nicolaus dropped their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $76.00 target price (down from $110.00) on shares of Cooper Companies in a report on Friday. Robert W. Baird lowered their price target on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a report on Friday, March 7th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a report on Thursday, May 22nd. Finally, Citigroup lowered their price target on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $101.63.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.